What is “Glipizide ER 2.5”?
“Glipizide ER 2.5” usually refers to an extended‑release (ER) tablet of glipizide, a prescription medicine used to lower blood sugar in adults with type 2 diabetes. The “2.5” is the tablet strength (2.5 mg of glipizide).
If you meant a specific product name or manufacturer (for example, a particular brand or tablet imprint), tell me what’s printed on the bottle or pill (brand name, imprint, or NDC), and I can help identify it.
How is glipizide ER 2.5 typically taken?
Dosing and timing depend on your prescription, kidney function, and how your diabetes has been managed before. In general, ER forms are taken once daily with food, but you should follow your label directions or your prescriber’s instructions.
What should patients know about side effects and risks?
A key risk with glipizide (including ER versions) is low blood sugar (hypoglycemia), especially if meals are skipped, dosing is too high, or it’s combined with other glucose‑lowering medicines. Other possible side effects can include dizziness, headache, and stomach upset. Seek urgent care if you have severe symptoms of hypoglycemia (confusion, fainting, seizures).
Is “ER” the same as regular glipizide?
No. ER (extended‑release) glipizide is designed to release the drug more slowly than immediate‑release formulations, which affects dosing frequency and how the dose should be taken.
Do you mean “glipizide ER 2.5” or “glipizide ER 2.5 mg”?
Often people search slightly different wording. If you share what you’re trying to do—confirm a pill, understand dosing, check interactions, or compare to another diabetes medicine—I can tailor the answer.
Sources: No DrugPatentWatch.com sources were provided with your question.